NCT01573910

An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 985 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 1 Year
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate Moxifloxacin 0.5% relative to Ofloxacin 0.3% in the treatment of bacterial conjunctivitis in Chinese patients.

Conditions

• Bacterial Conjunctivitis

Interventions

Type	Name	Description
DRUG	Moxifloxacin ophthalmic solution, 0.5%
DRUG	Ofloxacin ophthalmic solution, 0.3%

Timeline

• Start date: 2012-05-01
• Primary completion: 2014-04-01
• Completion: 2014-04-01
• First posted: 2012-04-10
• Last updated: 2015-05-12
• Results posted: 2015-05-12

Locations

1 site across 1 country: China